[Translation] A randomized, double-blind, multicenter phase III study of ADI-PEG 20+BSC vs. placebo+BSC in subjects with advanced hepatocellular carcinoma who failed prior systemic therapy
本试验是针对既往系统治疗失败的晚期肝细胞癌受试者,验证ADI-PEG20治疗的有效性和安全性。
[Translation] This trial is to verify the efficacy and safety of ADI-PEG20 treatment for patients with advanced hepatocellular carcinoma who have failed previous systemic therapy.